<?xml version="1.0" encoding="UTF-8"?>
<ref id="B68-vaccines-08-00273">
 <label>68.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Perkins</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Oâ€™Brien</surname>
    <given-names>L.M.</given-names>
   </name>
   <name>
    <surname>Laws</surname>
    <given-names>T.R.</given-names>
   </name>
   <name>
    <surname>Phillpotts</surname>
    <given-names>R.J.</given-names>
   </name>
  </person-group>
  <article-title>CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product</article-title>
  <source>Viral Immunol.</source>
  <year>2008</year>
  <volume>21</volume>
  <fpage>451</fpage>
  <lpage>458</lpage>
  <pub-id pub-id-type="doi">10.1089/vim.2008.0052</pub-id>
  <?supplied-pmid 19115934?>
  <pub-id pub-id-type="pmid">19115934</pub-id>
 </element-citation>
</ref>
